EPISODIC MIGRAINE
Clinical trials for EPISODIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new EPISODIC MIGRAINE trials appear
Sign up with your email to follow new studies for EPISODIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily pill could keep migraines at bay
Disease control CompletedThis study tested the safety of taking rimegepant every day to prevent episodic migraines. 441 adults with a history of migraines took a daily 75mg tablet for up to 52 weeks. Researchers tracked side effects and lab changes to see if long-term daily use is safe and tolerable.
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC
-
Daily pill shows promise for Long-Term migraine prevention
Prevention CompletedThis study tested the long-term safety of a daily pill called atogepant for preventing migraines in adults with chronic or episodic migraine. Over 156 weeks, 596 participants took 60 mg of atogepant each day. Researchers tracked side effects and lab results to see if the drug rem…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: AbbVie • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
Steroid boost for headache nerve blocks? new study checks
Symptom relief CompletedThis study tested whether adding a steroid called dexamethasone to a standard occipital nerve block (using numbing medicines) provides extra headache relief. 120 adults with various headache types received injections at the back of the head. Researchers tracked changes in headach…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC